Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
09/2005
09/29/2005CA2559208A1 Use and administration of bacterial efflux pump inhibitors
09/29/2005CA2558096A1 Pharmaceutical composition of (+)-erythro-mefloquine and its use in the treatment of an inflammatory condition
09/29/2005CA2558020A1 Use of renin inhibitors in therapy
09/29/2005CA2554637A1 Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous vascularisation disorder
09/29/2005CA2553933A1 Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous inflammation
09/29/2005CA2553932A1 Use of metronidazole for preparing a pharmaceutical composition for treating pathologies related to the b-type receptor of interleukin 8 and/or to a pacap type 1 receptor
09/28/2005EP1580556A1 Functional domain and associated molecule of dock2 essentially required in lymphocyte migration
09/28/2005EP1580266A1 Screening method
09/28/2005EP1580188A1 Aryl ureas as kinase inhibitors
09/28/2005EP1579872A1 Body weight gain inhibitor
09/28/2005EP1579871A1 Vascular endothelial cell growth factor antagonists and uses thereof
09/28/2005EP1578934A2 FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
09/28/2005EP1578931A2 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing an adenosine kinase
09/28/2005EP1578924A2 Genomic screen for epigenetically silenced tumor suppressor genes
09/28/2005EP1578912A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
09/28/2005EP1578902A2 Neurotransmission-associated proteins
09/28/2005EP1578899A2 Secreted proteins
09/28/2005EP1578816A1 Polymeric boronic acid derivatives as lipase inhibitors
09/28/2005EP1578782A2 Combination therapy with co-stimulatory factors
09/28/2005EP1578772A2 Cytokines and cytokine receptors with reduced immunogenicity
09/28/2005EP1578760A2 Compositions and methods for the diagnosis and treatment of tumor
09/28/2005EP1578448A1 Compositions of cholesteryl ester transfer protein inhibitors and hmg-coa reductase inhibitors
09/28/2005EP1578441A2 Polyphosphazene immunocstimulants
09/28/2005EP1578434A2 Methods and compositions relating to isoleucine boroproline compounds
09/28/2005EP1578431A2 Fat regulation
09/28/2005EP1578427A1 Use of gnrh agonists to support the luteal phase during infertility treatment
09/28/2005EP1578419A2 Immunostimulatory combinations
09/28/2005EP1578412A2 Pharmaceutical compositions and method of treating parkinson's disease
09/28/2005EP1578410A1 Method for preventing abuse of methylphenidate
09/28/2005EP1578409A1 Uses of adenosine a2a receptor antagonists
09/28/2005EP1578401A2 Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals
09/28/2005EP1578369A2 Screening strategy for anticancer drugs
09/28/2005EP1578366A2 Molecules preferentially associated with effector t cells or regulatory t cells and methods of their use
09/28/2005EP1578364A2 Compositions and methods for the treatmentof immune related diseases
09/28/2005EP1578362A2 Boroproline compound combination therapy
09/28/2005EP1578360A2 Conjoint administration of morphogens and ace inhibitors in treatment of chronic renal failure
09/28/2005EP1578351A2 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
09/28/2005EP1578346A2 Raf-mek-erk pathway inhibitors to treat cancer
09/28/2005EP1578345A2 Peptides and antibodies to muc 1 proteins
09/28/2005EP1578294A1 Methods and systems for enabling and stabilizing tooth movement
09/28/2005EP1578253A2 Prevention and treatment of synucleinopathic disease
09/28/2005EP1578193A2 Method for freeze-drying nucleic acid/block copolymer/cationic surfactant complexes
09/28/2005EP1439849A4 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease
09/28/2005EP1345937B1 Quinuclidine carbamate derivatives and their use as m3 antagonists
09/28/2005EP1289559B8 Combinations of enzyme inhibitor-containing preparations and the use thereof
09/28/2005EP1274458B1 Compositions containing a naphthalmide and an antiproliferative agent
09/28/2005EP1267905B1 Composition for the treatment of heart failure
09/28/2005EP1263787B1 G-protein coupled receptor
09/28/2005EP1222913B1 Depilating method
09/28/2005EP1135486B1 RECOMBINANT SOLUBLE Fc RECEPTORS
09/28/2005EP1104294B1 Compositions and methods of treating abnormal cell proliferation
09/28/2005EP1086099B1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
09/28/2005EP1051655B1 Methods and apparatus for accelerated orthokeratology
09/28/2005EP0963200B1 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid
09/28/2005CN1675206A Novel quinuclidine derivatives and medicinal compositions containing the same
09/28/2005CN1675171A Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
09/28/2005CN1674959A Use of a PPAR-alpha agonist to treat weight gain associated with a PPAR-gamma agonist treatment
09/28/2005CN1674942A Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
09/28/2005CN1674939A Novel combination of glucocorticoids and pde-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and COPD
09/28/2005CN1674938A Combination of VEGF receptor tyrosine kinase inhibitors for treatment of cancer
09/28/2005CN1674922A Methods of treating angiogenesis, tumor growth, and metastasis
09/28/2005CN1674918A Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s)
09/28/2005CN1674917A Treatment of human multiple myeloma by curcumin
09/28/2005CN1674916A The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
09/28/2005CN1674908A Therapeutic combinations of erb B kinase inhibitors and antineoplastic therapies
09/28/2005CN1674907A Use of reboxetine for the treatment of hot flashes
09/28/2005CN1674906A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors
09/28/2005CN1674898A 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections
09/28/2005CN1674896A Pharmaceutical compositions comprising FK506 derivatives and the ir use for the treatment of allergic diseases
09/28/2005CN1674880A Agonism of the 5HT2a receptor for treatment of thermoregulatory dysfunction
09/28/2005CN1674879A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
09/28/2005CN1674878A Immunomodulatory compositions, methods of making, and methods of use thereof
09/28/2005CN1674870A Liposomes containing biologically active compounds
09/28/2005CN1674795A Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
09/28/2005CN1673744A Treatment and diagnosis of cancer
09/28/2005CN1673368A HCV regulated proteins
09/28/2005CN1220521C Hapten-carrier conjugates for treating and preventing nicotine addiction
09/28/2005CN1220488C Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction
09/28/2005CN1220484C Microparticles for pulmonary administation
09/27/2005US6949655 Acyclic piperidine derivatives
09/27/2005US6949584 use in inhibiting angiogenesis in a mammal
09/27/2005US6949573 Substituted 3-amidopyridine derivatives are useful for treating inflammatory, allergic and respiratory diseases, as well as wounds
09/27/2005US6949563 (2-carboxamido)(3-amino)thiophene compounds
09/27/2005US6949558 Sequential administration of taxane and CDK1 antagonist for treatment of cancer, for inhibiting growth of tumors, and for inducing cellular apoptosis
09/27/2005US6949555 Use of organic compounds
09/27/2005US6949552 Remedial agent for anxiety neurosis or depression and piperazine derivative
09/27/2005US6949548 administering a synergistic combination of levosimendan or a pharmaceutically acceptable salt thereof and a beta-adrenergic receptor antagonist to a patient in need of such treatment
09/27/2005US6949547 Antidiabetic agents; central nervous system disorders; cardiovascular disorders; hypotensive agents; anticancer agents
09/27/2005US6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
09/27/2005US6949538 Compounds, compositions, and methods
09/27/2005US6949531 14 β, 16, 17-methylene steroids as novel androgens
09/27/2005US6949529 Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
09/27/2005US6949527 Muscle relaxation
09/27/2005US6949522 treating or preventing HIV infection, HBV infection or abnormal cellular proliferation by administering said compounds or the related beta -D and beta -L-2'-halo-4'-thionucleosides
09/27/2005US6949514 Administering to a subject in need of such treatment, an agent in an amount effective to inhibit proliferation
09/27/2005US6949510 Uses of diterpenoid triepoxides as an anti-proliferative agent
09/27/2005US6949356 Methods for improving secondary metabolite production in fungi
09/27/2005US6949354 Detection of nervous system modulators; obtain preferential nervous system tissue in vitro, culture, incubate with modulator, monitor and evaluate adjustment in cell activity
09/27/2005US6949349 incubating a phagemid clone displaying the peptide, with the IGF in the presence of the IGFBP at high and low concentrations of the phagemid clone, measuring the degree to which binding of the phagemid clone to the IGFBP is inhibited by IGF
09/27/2005US6949261 An isolate from the leaves of Gymnema sylvestre obtained by extracting Gymnema sylvestre leaves with aqueous ethanol, removing acid-insoluble salt from the extract, concentrating desalted extract, isolating an insulinotropically active principle
1 ... 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 ... 1151